Stocks
British American Tobacco Financial Statements (BTI) |
||||||||||
| British American Tobaccosmart-lab.ru | % | 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2021 | 08.03.2022 | 31.12.2022 | 02.03.2023 | 09.02.2024 | 08.02.2024 | ||||
| Currency | GBP | GBP | GBP | GBP | GBP | GBP | ||||
| Financial report URL | ||||||||||
| Revenue, £ | ? | 34 732 984 434 | 25 684 000 000 | 27 655 000 000 | 27 655 000 000 | 27 283 000 000 | 34 204 000 000 | |||
| Operating Income, £ | 14 818 721 516 | 10 234 000 000 | 10 523 000 000 | 10 523 000 000 | -15 751 000 000 | 15 860 500 000 | ||||
| EBITDA, £ | ? | 16 211 611 018 | 11 763 000 000 | 12 714 000 000 | 12 714 000 000 | 9 948 000 000 | 16 800 500 000 | |||
| Net profit, £ | ? | 9 180 899 833 | 6 801 000 000 | 6 666 000 000 | 6 666 000 000 | -14 367 000 000 | -23 586 500 000 | |||
| OCF, £ | ? | 9 717 000 000 | 9 717 000 000 | 10 394 000 000 | 10 394 000 000 | 10 714 000 000 | 12 846 500 000 | |||
| CAPEX, £ | ? | 745 000 000 | 745 000 000 | 656 000 000 | 656 000 000 | 601 000 000 | 776 000 000 | |||
| FCF, £ | ? | 8 972 000 000 | 8 972 000 000 | 9 738 000 000 | 9 738 000 000 | 10 113 000 000 | 12 070 500 000 | |||
| Dividend payout, £ | 4 904 000 000 | 4 904 000 000 | 4 915 000 000 | 4 915 000 000 | 5 055 000 000 | 3 874 500 000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 53.4% | 72.1% | 73.7% | 73.7% | 0.00% | -16.4% | ||||
| OPEX, £ | 14 183 131 161 | 11 065 000 000 | 7 822 000 000 | 7 822 000 000 | 33 264 000 000 | 22 934 500 000 | ||||
| Cost of production, £ | 6 216 614 602 | 4 382 000 000 | 4 554 000 000 | 4 554 000 000 | 4 641 000 000 | 9 517 500 000 | ||||
| R&D, £ | 411 105 251 | 141 000 000 | 138 000 000 | 138 000 000 | 181 000 000 | 311 000 000 | ||||
| Interest expenses, £ | 1 941 931 383 | 1 521 000 000 | 1 663 000 000 | 1 663 000 000 | 1 887 000 000 | 1 935 000 000 | ||||
| Assets, £ | 0.000 | 137 365 000 000 | 153 546 000 000 | 153 546 000 000 | 118 716 000 000 | 118 716 000 000 | ||||
| Net Assets, £ | ? | 67 545 674 604 | 67 101 000 000 | 75 368 000 000 | 75 368 000 000 | 52 566 000 000 | 52 566 000 000 | |||
| Debt, £ | 39 658 000 000 | 43 139 000 000 | 43 139 000 000 | 39 730 000 000 | 39 730 000 000 | |||||
| Cash, £ | 4 415 324 489 | 3 265 000 000 | 4 025 000 000 | 4 025 000 000 | 2 964 000 000 | 2 964 000 000 | ||||
| Net debt, £ | -4 415 324 489 | 36 393 000 000 | 39 114 000 000 | 39 114 000 000 | 36 766 000 000 | 36 766 000 000 | ||||
| Ordinary share price, rub | 37.4 | 37.4 | 40.0 | 40.0 | 29.3 | 41.2 | ||||
| Number of ordinary shares, mln | 2 296 684 708 | 2 287 000 000 | 2 266 872 216 | 2 256 000 000 | 2 229 000 000 | 2 230 456 075 | ||||
| Market cap, £ | 85 918 974 926 | 85 556 670 000 | 90 629 551 196 | 90 194 880 000 | 65 287 410 000 | 91 827 876 608 | ||||
| EV, £ | ? | 81 503 650 437 | 121 949 670 000 | 129 743 551 196 | 129 308 880 000 | 102 053 410 000 | 128 593 876 608 | |||
| Book value, £ | -88 816 314 387 | -48 524 000 000 | -53 707 000 000 | -53 707 000 000 | -42 996 000 000 | -42 996 000 000 | ||||
| EPS, rub | ? | 4.00 | 2.97 | 2.94 | 2.95 | -6.45 | -10.6 | |||
| FCF/share, rub | 3.91 | 3.92 | 4.30 | 4.32 | 4.54 | 5.41 | ||||
| BV/share, rub | -38.7 | -21.2 | -23.7 | -23.8 | -19.3 | -19.3 | ||||
| EBITDA margin, % | ? | 46.7% | 45.8% | 46.0% | 46.0% | 36.5% | 49.1% | |||
| Net margin, % | ? | 26.4% | 26.5% | 24.1% | 24.1% | -52.7% | -69.0% | |||
| FCF yield, % | ? | 10.4% | 10.5% | 10.7% | 10.8% | 15.5% | 13.1% | |||
| ROE, % | ? | 13.6% | 10.1% | 8.84% | 8.84% | -27.3% | -44.9% | |||
| ROA, % | ? | 4.95% | 4.34% | 4.34% | -12.1% | -19.9% | ||||
| P/E | ? | 9.36 | 12.6 | 13.6 | 13.5 | -4.54 | -3.89 | |||
| P/FCF | 9.58 | 9.54 | 9.31 | 9.26 | 6.46 | 7.61 | ||||
| P/S | ? | 2.47 | 3.33 | 3.28 | 3.26 | 2.39 | 2.68 | |||
| P/BV | ? | -0.97 | -1.76 | -1.69 | -1.68 | -1.52 | -2.14 | |||
| EV/EBITDA | ? | 5.03 | 10.4 | 10.2 | 10.2 | 10.3 | 7.65 | |||
| Debt/EBITDA | -0.27 | 3.09 | 3.08 | 3.08 | 3.70 | 2.19 | ||||
| R&D/CAPEX, % | 55.2% | 18.9% | 21.0% | 21.0% | 30.1% | 40.1% | ||||
| CAPEX/Revenue, % | 2.14% | 2.90% | 2.37% | 2.37% | 2.20% | 2.27% | ||||
| British American Tobacco shareholders | ||||||||||
